Lonza nominates Pearl Huang to its board. What it means for Lonza Group stock
Published on 10/04/2026 at 18:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Lonza Group announced on September 30, 2026, that it had nominated Pearl Huang as an independent member of its Board of Directors, subject to election at the company's annual general meeting in May 2027, according to the EQS company announcement carried by FT.com.
At 6:34 p.m. CEST on October 4, 2026, Lonza Group stock was EUR 609.50 in weekend trading at Lang & Schwarz. The price was unchanged at 0.00 percent versus the EUR 609.50 close at Lang & Schwarz on October 2, 2026.
Weekend trading
Lang & Schwarz listed a bid of EUR 609.20 and an ask of EUR 609.80 at the quoted time. The further course of weekend trading at Lang & Schwarz until 7:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Lonza Group stock.
Board nomination
Subject to her election, Huang would also join Lonza's Strategy and Innovation Committee and Remuneration Committee. The announcement said Angelica Kohlmann and Christoph Mäder will not stand for re-election at the 2027 annual general meeting. Lonza said its Board will have added eight new members since 2024. The company described Huang as having leadership experience in the pharmaceutical and biotechnology industries and scientific expertise in drug discovery and innovation, according to the EQS release carried by FT.com.
Next Xetra session
The next Xetra session is scheduled for October 5, 2026.
